Novartis received FDA approval for Fabhaltaï¾® (iptacopan) as the first oral monotherapy for adults with PNH
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhaltaï¾® (iptacopan)…
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhaltaï¾® (iptacopan)…
On Dec. 3, 2023, the Bill & Melinda Gates Foundation announced that global donors at COP28 had pledged…
On Nov. 30, 2023, the U.S. Department of Department of Agricultureï¾’s (USDA) Animal and Plant Health Inspection Service…
On Nov. 30, 2023, researchers at Tufts University announced they had created tiny biological robots that they call…
On Nov. 30, 2023, researchers at Hokkaido University, in collaboration with colleagues at Woods Hole Oceanographic Institution announced…
On Nov. 29, 2023, the World Health Organization (WHO) announced that between 24 and 25 November 2023, the…
On Nov. 29, 2023, the BC Centre for Disease Controlr Disease Control (BCCDC) announced that a A passenger…
On Nov. 28, 2023, Novavax announced that Nuvaxovidï¾™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
On Nov. 28, 2023, Emergent BioSolutions announced that the Biomedical Advanced Research and Development Authority (BARDA) within the…
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
On Nov. 27, 2023, the U.S. Food and Drug Administration approved SpringWorks’ Ogsiveo (nirogacestat) tablets for adult patients…
On Nov. 27, 2023, the CDCï¾’s Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…
On Nov. 23, 2023, Vertex announced that the European Medicines Agency (EMA) had validated a Type II variation…
On Nov. 23, 2023, the World Health Organization (WHO) announced that it was monitoring data from Chinese surveillance…
On Nov. 22, 2023, the U.S. Food and Drug Administration issued the final guidance COVID-19: Developing Drugs and…
On Nov. 21, 2023, the World Health Organization (WHO) reported that the BA.2.86 variant had been reported in…
On Nov. 17, 2023, the Oregon Department of Agriculture reported that the United States Department of Agricultureï¾’s National…
On Nov. 17, 2023, the U.S. Department of Agriculture’s (USDA) announced the National Strategic Germplasm and Cultivar Collection…
On Nov. 16, 2023, the CDC announced the release of more than 77,000 additional doses of Beyfortusï¾™ (nirsevimab-alip…
On Nov. 16. 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Following years of…
On Nov. 15, 2023, the U.S. Food and Drug Administration granted marketing authorization to LetsGetChecked for the Simple…
On Nov. 14, 2023, Yellowstone National Park and the Wyoming Game and Fish Department (WGFD) confirmed the presence…
On Nov. 13, 2023, the Journal JAMA reported evidence that showed COVID-19 had widened the gendered life expectancy…
On Nov. 13, 2023, the U.S. Department of Department of Agriculture (USDA) announced that researchers have reclassified the…
On Nov. 10, 2023, the CDC estimated that from Oct. 1, 2023, through Nov. 11, 2023, there were…
On Nov. 9, 2023, the U.S. Food and Drug Administration approved Valneva’s Ixchiq, the first chikungunya vaccine. Ixchiq…
On Nov. 9, 2023, the U.S. Food and Drug Administration approved ‘ Takeda PharmaceuticalsVAdzynma, the first recombinant (genetically…
On Nov. 9, 2023, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) antigen…
On Nov. 9, 2023, the National Institute of health (NIH) announced that Monica M. Bertagnolli, M.D., had begun…
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…